ACMG Highlights

ACMG-ASHG-NSGC Joint Response to Supreme Court Decision to Overrule Roe v Wade (2022)
Dobbs v. Jackson Final.ACMG-2022.pdf

Learn More

ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG) (includes supplemental material)
Secondary-Findings-v3.1

Learn More

Krabbe Disease (Infantile Form) Newborn Screening ACT Sheet
Krabbe-Infantile

Learn More

Upcoming Events

Join us for the 2022 ACMG Summer Gene Therapy Education Series: Advancements in Gene Therapy Options for Rare Diseases.
These 4 live webinars are FREE & will provide a background on gene therapy for all healthcare professionals.
Learn More


New ACCME standards are now in effect as of January 1, 2022
Learn More


Medical Necessity Webinar Series from the National Coordinating Center for the Regional Genetics Networks (NCC) and the Catalyst Center

Wednesday, June 29, 3:00 – 4:00 pm ET
Time:1:00 pm- 2:00 PM ET

Interested in learning more about what medical necessity is and how evidence is used to inform policy? Join the National Coordinating Center for the Regional Genetics Networks (NCC) and The Catalyst Center for Part 3 of a three-part webinar series about medical necessity.
Register Now!


ACMG Genetics101 for Healthcare Providers
Learn More


2022 ACMG Annual Clinical Genetics Meeting Digital Edition
Learn More

News and Releases

ACMG-ASHG-NSGC Joint Response to Supreme Court Decision to Overrule Roe v Wade (2022)
Dobbs v. Jackson Final.ACMG-2022.pdf

Learn More

ACMG Releases Update to Secondary Findings Gene List; SF v3.1 Adds Five Genes, Including One with Variant Linked to Heart Failure in Underrepresented Populations
ACMG Releases Update to Secondary Findings Gene List; SF v3.1 Adds Five Genes-T-final.6.9

Learn More

The Application of Noninvasive Prenatal Screening Using Cell-free DNA in General Risk Pregnancies – The American College of Medical Genetics and Genomics Publishes its Highly Anticipated Evidence-based Review
Application of Noninvasive Prenatal Screening Using Cell-free DNA in General Risk Pregnancies final

Learn More